Bruce Lahn On Raising $80 Million To Build A Global Company Providing Gene Delivery Technologies To Enable Research And Clinical Studies

A scientist-turned-entrepreneur, Bruce Lahn has successfully transitioned from academia to leading businesses like VectorBuilder and Cyagen, reshaping gene delivery and genetic research. Here's a dive into his extraordinary path and the lessons he's gleaned along the way. VectorBuilder has attracted funding from top-tier investors like Legend Capital, Operation Holding Group, Wanlian Securities Co., Guangzhou Yuexiu Industrial Investment Fund Management, and China Chengtong.